A new 'Triple-G' weight loss drug, targeting three metabolic receptors, has demonstrated significant efficacy in trials. Patients on even the lowest dose achieved an average weight loss of 12.7%, signaling a potential breakthrough in the pharmaceutical sector.
'Triple-G' Weight Loss Drug Shows 12.7% Weight Reduction in Trials
pharmaceuticalsweight_loss_drugsclinical_trialsbiotechnologydrug_development
